Table 6.

HMPXV-vaccine-related perceptions of Czech HCWs responding to the HMPXV survey, September 2022 (n = 341).

Category	Item	HMPXV Vaccine Rejection (n = 153)	HMPXV Vaccine Hesitancy (n = 158)	HMPXV Vaccine Acceptance (n = 30)	Total (n = 341)	p
Perceived Susceptibility	1. Due to my occupation.	2.0 ± 0.9	2.7 ± 0.9	3.4 ± 1.2	2.5 ± 1.0	<0.001
	2. Due to lifestyle and health status.	1.7 ± 0.9	2.2 ± 0.8	2.5 ± 1.2	2.0 ± 0.9	<0.001
	3. Not vaccinated vs. smallpox.	1.8 ± 0.9	2.4 ± 0.8	2.9 ± 1.3	2.2 ± 1.0	<0.001
	Overall score (3–15)	5.6 ± 2.3	7.2 ± 2.1	8.8 ± 2.9	6.6 ± 2.5	<0.001
Perceived Severity	1. I will be very sick.	3.2 ± 1.0	3.3 ± 0.8	3.8 ± 1.0	3.3 ± 0.9	0.004
	2. I may require hospitalisation.	2.8 ± 1.0	2.9 ± 0.7	3.2 ± 1.3	2.9 ± 0.9	0.195
	3. I might die.	2.9 ± 1.0	3.0 ± 0.8	3.4 ± 1.1	3.0 ± 0.9	0.130
	Overall score (3–15)	8.9 ± 2.4	9.1 ± 1.8	10.3 ± 2.9	9.1 ± 2.2	0.011
Perceived Benefits	1. Protected from getting infected.	3.0 ± 0.8	3.3 ± 0.7	3.8 ± 0.8	3.2 ± 0.8	<0.001
	2. Protected from serious complications.	3.3 ± 0.8	3.6 ± 0.6	4.4 ± 0.7	3.5 ± 0.8	<0.001
	3. Protect my patients and family.	2.9 ± 1.0	3.3 ± 0.7	4.1 ± 0.9	3.2 ± 0.9	<0.001
	Overall score (3–15)	9.1 ± 2.3	10.1 ± 1.6	12.2 ± 2.0	9.9 ± 2.1	<0.001
Perceived Barriers	1. Safety of HMPXV vaccine.	3.1 ± 1.0	3.0 ± 0.7	2.7 ± 1.3	3.0 ± 0.9	0.038
	2. Effectiveness of HMPXV vaccine.	3.0 ± 1.0	2.9 ± 0.7	2.6 ± 1.3	2.9 ± 0.9	0.035
	Overall score (2–10)	6.1 ± 1.9	5.9 ± 1.3	5.3 ± 2.6	6.0 ± 1.7	0.015
Cues to Action	1. Mandated by the employer.	2.4 ± 1.0	3.3 ± 0.8	3.5 ± 1.5	2.9 ± 1.1	<0.001
	2. Recommended by health authorities.	2.4 ± 1.0	3.3 ± 0.8	3.9 ± 1.2	3.0 ± 1.0	<0.001
	3. Reliable evidence on effectiveness and safety.	3.0 ± 1.1	3.7 ± 0.8	4.2 ± 0.9	3.4 ± 1.0	<0.001
	Overall score (3–15)	7.9 ± 2.6	10.3 ± 1.9	11.6 ± 2.9	9.3 ± 2.7	<0.001

The Kruskal–Wallis (H) test was used, with a significance level (p) of ≤0.05.